Stocks
Harrow, Inc.HROW
NASDAQHealthcarePharmaceuticals$27.64
Price as of · delayed, not real-time
A specialty pharmaceutical company focused on developing and commercializing ophthalmic products, including prescription eye drops and surgical solutions. Its portfolio targets underserved conditions in ophthalmology, and investors track it for its pipeline progress and commercial execution in a niche but growing market.
52W Range: $26.96-$54.85
Congressional Interest in Harrow, Inc. (HROW)
No congressional trades have been disclosed for Harrow, Inc. (HROW) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading HROW?
No congressional trades found for this stock.